The WACC of Diagnos Inc (ADK.V) is 6.1%.
Range | Selected | |
Cost of equity | 5.1% - 7.4% | 6.25% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 7.0% - 7.9% | 7.45% |
WACC | 5.1% - 7.2% | 6.1% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.24 | 0.41 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.1% | 7.4% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.13 | 0.13 |
Cost of debt | 7.0% | 7.9% |
After-tax WACC | 5.1% | 7.2% |
Selected WACC | 6.1% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
ADK.V | Diagnos Inc | 0.13 | 0.41 | 0.38 |
ADHC | American Diversified Holdings Corp | 0.06 | 0.17 | 0.16 |
CRVW | CareView Communications Inc | 1.38 | 0.47 | 0.24 |
CSOC | Caduceus Software Systems Corp | 0.02 | -0.76 | -0.75 |
CYCA | Cytta Corp | 0.17 | 0.09 | 0.08 |
MITI | Mitesco Inc | 0.38 | -1.16 | -0.91 |
MOST | MobileSmith Inc | 0.08 | -0.69 | -0.65 |
SPOM | SPO Global Inc | 13.51 | 0.42 | 0.04 |
VGL.V | Vigil Health Solutions Inc | 0.03 | 0.57 | 0.55 |
VMCS | VisualMED Clinical Solutions Corp | 0.55 | -0.51 | -0.36 |
Low | High | |
Unlevered beta | -0.12 | 0.11 |
Relevered beta | -0.13 | 0.12 |
Adjusted relevered beta | 0.24 | 0.41 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for ADK.V:
cost_of_equity (6.25%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.24) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.